Published on in Vol 9 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/60676, first published .
Cardiac Self-Efficacy Improvement in a Digital Heart Health Program: Secondary Analysis From a Feasibility and Acceptability Pilot Study

Cardiac Self-Efficacy Improvement in a Digital Heart Health Program: Secondary Analysis From a Feasibility and Acceptability Pilot Study

Cardiac Self-Efficacy Improvement in a Digital Heart Health Program: Secondary Analysis From a Feasibility and Acceptability Pilot Study

1Clinical Research Department, Lark Health, 809 Cuesta Dr. Suite B #1033, Mountain View, CA, United States

2Digital Health Technologies Department, Roche Information Solutions, Santa Clara, CA, United States

Corresponding Author:

Sarah A Graham, PhD


Background: Lifestyle modification programs play a critical role in preventing and managing cardiovascular disease (CVD). A key aim of many programs is improving patients’ self-efficacy. In-person lifestyle modification programs can enhance self-efficacy in managing CVD risk, also known as cardiac self-efficacy (CSE). However, such programs are typically staffing and resource intensive. Digital lifestyle modification programs may offer a scalable and accessible way to improve CSE, but this has not been shown in prior research.

Objective: This study examined changes in CSE among individuals using a digital lifestyle modification program for cardiovascular health. Evaluation of improvement in CSE was a secondary goal of a feasibility and acceptability pilot study of a digital program for Heart Health.

Methods: Participants were individuals with elevated risk for CVD who enrolled in a 90-day pilot study that involved mobile app–based, artificial intelligence–powered health coaching and educational lessons focused on behaviors that promote cardiovascular health. Participants completed the 9-item CSE Scale at baseline and in month 2. Changes in confidence in participants’ ability to manage their cardiovascular health were assessed.

Results: The sample included 273 (n=207, 61.2% female; mean age 59.3, SD 10.1 years) participants who submitted a complete CSE Scale at baseline and in month 2. The total CSE Scale score increased by 12.9% (P<.001) from baseline to month 2. Additionally, there were significant increases in mean score on each of the 9 individual CSE Scale items (all P<.001), with the largest increases in confidence “in knowing when to call or visit the doctor for your heart disease” (17% increase; P<.001), “in knowing how much physical activity is good for you” (16.3% increase; P<.001), and “that you can get regular aerobic exercise” (19% increase; P<.001).

Conclusions: The present analyses indicate that participants in a digital lifestyle modification program for cardiovascular health showed significant improvements in CSE within 2 months. This work adds to the growing literature examining ways to improve health-related self-efficacy and scalable access to programs for prevention and management of CVD.

JMIR Form Res 2025;9:e60676

doi:10.2196/60676

Keywords



Background

Cardiovascular disease (CVD) is the leading cause of death and the most common chronic disease in the United States, with 126.9 million adults (nearly 50% of the population) living with some form of CVD [Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. Feb 22, 2022;145(8):e153-e639. [CrossRef] [Medline]1]. CVD is a key public health concern, as well as an economic burden, with costs related to CVD estimated to be US $378 billion, exceeding all other chronic health conditions [Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. Feb 22, 2022;145(8):e153-e639. [CrossRef] [Medline]1,McClellan M, Brown N, Califf RM, Warner JJ. Call to action: urgent challenges in cardiovascular disease: a presidential advisory from the American Heart Association. Circulation. Feb 26, 2019;139(9):e44-e54. [CrossRef] [Medline]2]. Prevention and risk reduction for patients at risk for CVD is important to reduce mortality, disability, and economic burden [Rippe JM. Lifestyle strategies for risk factor reduction, prevention, and treatment of cardiovascular disease. Am J Lifestyle Med. 2019;13(2):204-212. [CrossRef] [Medline]3]. According to the American Heart Association, engaging in a healthy lifestyle over the course of one’s lifespan is the most important factor in CVD prevention [Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. Sep 10, 2019;140(11):e596-e646. [CrossRef] [Medline]4]. As maintaining a healthy lifestyle is difficult for many adults [Kris-Etherton PM, Petersen KS, Velarde G, et al. Barriers, opportunities, and challenges in addressing disparities in diet-related cardiovascular disease in the United States. J Am Heart Assoc. Apr 7, 2020;9(7):e014433. [CrossRef] [Medline]5], 1 method of CVD prevention and management is participation in behavioral interventions focused on healthy lifestyle modifications [Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. Sep 10, 2019;140(11):e596-e646. [CrossRef] [Medline]4]. Position statements from the US Preventive Services Task Force state that lifestyle modification programs that emphasize a healthy diet and physical activity have a wide variety of cardiovascular health benefits and CVD risk reduction among individuals with and without a diagnosis of CVD [US Preventive Services Task Force, Krist AH, Davidson KW, et al. Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: US Preventive Services Task Force recommendation statement. JAMA. Nov 24, 2020;324(20):2069-2075. [CrossRef] [Medline]6-US Preventive Services Task Force, Mangione CM, Barry MJ, et al. Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults without cardiovascular disease risk factors: US Preventive Services Task Force recommendation statement. JAMA. Jul 26, 2022;328(4):367-374. [CrossRef] [Medline]8]. To enable individuals to make lasting behavior changes to improve their cardiovascular health, a key aim of many lifestyle modification programs is improving patients’ self-efficacy to manage their health [Patnode CD, Redmond N, Iacocca MO, Henninger M. Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults without known cardiovascular disease risk factors: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. Jul 26, 2022;328(4):375-388. [CrossRef] [Medline]7,Foroumandi E, Kheirouri S, Alizadeh M. The potency of education programs for management of blood pressure through increasing self-efficacy of hypertensive patients: a systematic review and meta-analysis. Patient Educ Couns. Mar 2020;103(3):451-461. [CrossRef] [Medline]9,Katch H, Mead H. The role of self-efficacy in cardiovascular disease self-management: a review of effective programs. PI. 2010;2010(2):33-44. [CrossRef]10].

Importance of Self-Management in CVD

Self-efficacy, or confidence in one’s ability to execute and control certain behaviors, is crucial for patient empowerment and self-management of cardiovascular health [Brady TJ, Murphy L, O’Colmain BJ, et al. A meta-analysis of health status, health behaviors, and health care utilization outcomes of the Chronic Disease Self-Management Program. Prev Chronic Dis. 2013;10:120112. [CrossRef] [Medline]11]. There are several evaluation tools for measuring self-efficacy in the context of disease self-management. For instance, general scales for managing chronic disease include the Chronic Disease Self-Efficacy Scale [Lorig K, Stewart A, Ritter P, González V, et al. Outcome Measures for Health Education and Other Health Care Interventions. Sage Publications, Inc; 1996. ISBN: 978-0-7619-0066-512] and the Self-Efficacy for Managing Chronic Disease 6-Item Scale [Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001;4(6):256-262. [Medline]13]. The Cardiac Self-Efficacy (CSE) Scale is a measure of self-efficacy specifically for self-management of CVD [Sullivan MD, LaCroix AZ, Russo J, Katon WJ. Self-efficacy and self-reported functional status in coronary heart disease: a six-month prospective study. Psychosom Med. 1998;60(4):473-478. [CrossRef] [Medline]14]. The CSE Scale is a self-report survey that evaluates individuals’ beliefs in their ability to manage their cardiovascular health and the challenges that come with heart disease [Sullivan MD, LaCroix AZ, Russo J, Katon WJ. Self-efficacy and self-reported functional status in coronary heart disease: a six-month prospective study. Psychosom Med. 1998;60(4):473-478. [CrossRef] [Medline]14,Fors A, Ulin K, Cliffordson C, Ekman I, Brink E. The Cardiac Self-Efficacy Scale, a useful tool with potential to evaluate person-centred care. Eur J Cardiovasc Nurs. Dec 2015;14(6):536-543. [CrossRef] [Medline]15]. These self-efficacy evaluation tools provide insight into how confident an individual feels about carrying out behaviors that are beneficial to disease prevention and self-management.

Self-Efficacy in CVD Prevention and Management

Self-efficacy is a key target of lifestyle modification programs because it predicts a range of healthy behaviors and outcomes among individuals with CVD. For instance, higher self-efficacy is associated with greater engagement in self-care behaviors [Ea EE, Colbert A, Turk M, Dickson VV. Self-care among Filipinos in the United States who have hypertension. Appl Nurs Res. Feb 2018;39:71-76. [CrossRef] [Medline]16,Tan F, Oka P, Dambha-Miller H, Tan NC. The association between self-efficacy and self-care in essential hypertension: a systematic review. BMC Fam Pract. Feb 22, 2021;22(1):44. [CrossRef] [Medline]17], such as higher levels of physical activity [Garland M, Wilbur J, Fogg L, Halloway S, Braun L, Miller A. Self-efficacy, outcome expectations, group social support, and adherence to physical activity in African American women. Nurs Res. 2021;70(4):239-247. [CrossRef] [Medline]18], healthier dietary habits [Kang A, Dulin A, Risica PM. Relationship between adherence to diet and physical activity guidelines and self-efficacy among black women with high blood pressure. J Health Psychol. Mar 2022;27(3):663-673. [CrossRef] [Medline]19], and better medication adherence [Warren-Findlow J, Seymour RB. Prevalence rates of hypertension self-care activities among African Americans. J Natl Med Assoc. Jun 2011;103(6):503-512. [CrossRef] [Medline]20]. Among cardiac patients, higher self-efficacy is also associated with better attendance in cardiac rehabilitation programs [Jackson L, Leclerc J, Erskine Y, Linden W. Getting the most out of cardiac rehabilitation: a review of referral and adherence predictors. Heart. Jan 2005;91(1):10-14. [CrossRef] [Medline]21]. Meta-analytic results also indicate that stronger self-efficacy among those with CVD is linked with a range of metrics of health-related quality of life, such as physical functioning and mobility, emotional functioning, mental health, and social functioning [Banik A, Schwarzer R, Knoll N, Czekierda K, Luszczynska A. Self-efficacy and quality of life among people with cardiovascular diseases: a meta-analysis. Rehabil Psychol. May 2018;63(2):295-312. [CrossRef] [Medline]22].

A review of the literature indicated that in-person lifestyle modification programs for CVD have been successful in improving health-related self-efficacy [Katch H, Mead H. The role of self-efficacy in cardiovascular disease self-management: a review of effective programs. PI. 2010;2010(2):33-44. [CrossRef]10]. One program involved 6 weeks of in-person, 2.5-hour educational sessions led by trained peer leaders who received 4 days of training; results of this study showed significant improvements in self-efficacy related to managing their health [Lorig KR, Ritter PL, González VM. Hispanic chronic disease self-management: a randomized community-based outcome trial. Nurs Res. 2003;52(6):361-369. [CrossRef] [Medline]23]. Another program that included 8 hour-long, individual sessions between each patient and a health professional found significant increases in self-efficacy related to self-care after 12 weeks [DeWalt DA, Pignone M, Malone R, et al. Development and pilot testing of a disease management program for low literacy patients with heart failure. Patient Educ Couns. Oct 2004;55(1):78-86. [CrossRef] [Medline]24].

There is also evidence that in-person lifestyle modification programs can improve self-efficacy specific to managing cardiovascular health, as measured by the CSE Scale. Recent studies show that intensive, in-person lifestyle modification programs for CVD led by nurses and health professionals can improve CSE scores over time [Bagheri H, Shakeri S, Nazari AM, et al. Effectiveness of nurse-led counselling and education on self-efficacy of patients with acute coronary syndrome: a randomized controlled trial. Nurs Open. Jan 2022;9(1):775-784. [CrossRef] [Medline]25,McKenzie KM, Park LK, Lenze EJ, et al. A prospective cohort study of the impact of outpatient intensive cardiac rehabilitation on depression and cardiac self-efficacy. Am Heart J Plus. Jan 2022;13:100100. [CrossRef] [Medline]26], which have been shown to lead to downstream improvement of health behaviors and outcomes over time [Sullivan MD, LaCroix AZ, Russo J, Katon WJ. Self-efficacy and self-reported functional status in coronary heart disease: a six-month prospective study. Psychosom Med. 1998;60(4):473-478. [CrossRef] [Medline]14,Kang Y, Yang IS, Kim N. Correlates of health behaviors in patients with coronary artery disease. Asian Nurs Res (Korean Soc Nurs Sci). Mar 2010;4(1):45-55. [CrossRef] [Medline]27,Sarkar U, Ali S, Whooley MA. Self-efficacy as a marker of cardiac function and predictor of heart failure hospitalization and mortality in patients with stable coronary heart disease: findings from the Heart and Soul Study. Health Psychol. Mar 2009;28(2):166-173. [CrossRef] [Medline]28].

The evidence reviewed here shows that, although in-person programs have succeeded in improving self-efficacy, these intensive programs typically involve a high degree of human contact and staffing resources; this makes them difficult to implement or impossible to scale up to larger populations. Moreover, in-person programs can present access challenges to patients, such as having to travel long distances to attend [Jackson L, Leclerc J, Erskine Y, Linden W. Getting the most out of cardiac rehabilitation: a review of referral and adherence predictors. Heart. Jan 2005;91(1):10-14. [CrossRef] [Medline]21]. As such, scalable and accessible lifestyle modification programs to improve CSE are needed.

Digital Health and CSE

Recent years have seen an increase in the availability of digital lifestyle modification programs for CVD prevention and management [Mahajan S, Lu Y, Spatz ES, Nasir K, Krumholz HM. Trends and predictors of use of digital health technology in the United States. Am J Med. Jan 2021;134(1):129-134. [CrossRef] [Medline]29-Zwack CC, Haghani M, Hollings M, et al. The evolution of digital health technologies in cardiovascular disease research. npj Digit Med. Jan 3, 2023;6(1):1-11. [CrossRef]31]. These digital health solutions have become increasingly available and can provide many benefits over in-person programs, such as increased accessibility, on-demand support, availability outside of typical working hours, lower cost, and scalability to larger populations [Frederix I, Caiani EG, Dendale P, et al. ESC e-Cardiology Working Group position paper: overcoming challenges in digital health implementation in cardiovascular medicine. Eur J Prev Cardiol. Jul 2019;26(11):1166-1177. [CrossRef] [Medline]32]. These benefits have the potential to increase participation in lifestyle modifications for CVD [Wongvibulsin S, Habeos EE, Huynh PP, et al. Digital health interventions for cardiac rehabilitation: systematic literature review. J Med Internet Res. Feb 8, 2021;23(2):e18773. [CrossRef] [Medline]30]. Moreover, digital health programs for CVD prevention and management can significantly improve patient behaviors and show promise in delivering care that is accessible, cost-effective, and patient-focused [Gray R, Indraratna P, Lovell N, Ooi SY. Digital health technology in the prevention of heart failure and coronary artery disease. Cardiovasc Digit Health J. Dec 2022;3(6 Suppl):S9-S16. [CrossRef] [Medline]33].

Despite these benefits, many outcomes including CSE, remain unexplored in digital lifestyle modification programs and more evidence is required [Zwack CC, Haghani M, Hollings M, et al. The evolution of digital health technologies in cardiovascular disease research. npj Digit Med. Jan 3, 2023;6(1):1-11. [CrossRef]31]. There is some evidence that digital interventions can increase general self-efficacy [Devi R, Powell J, Singh S. A web-based program improves physical activity outcomes in a primary care angina population: randomized controlled trial. J Med Internet Res. Sep 12, 2014;16(9):e186. [CrossRef] [Medline]34,Newby K, Teah G, Cooke R, et al. Do automated digital health behaviour change interventions have a positive effect on self-efficacy? A systematic review and meta-analysis. Health Psychol Rev. Mar 2021;15(1):140-158. [CrossRef] [Medline]35], suggesting that it may be possible for digital CVD programs to improve CSE. However, use of the CSE Scale in digital health studies is extremely limited. As such, the main objective of the present analyses was to test whether participation in an artificial intelligence (AI)–powered digital lifestyle modification program for heart health led to improved CSE.

Heart Health Program

The Lark Heart Health (Lark Technologies, Inc) program is a newly developed AI-powered lifestyle modification program that provides health behavior coaching to prevent and manage atherosclerotic CVD and coronary artery disease by targeting key CVD risk factors. We evaluated the acceptability and feasibility of this new program in a pilot study; a detailed study description and main outcome results for this pilot study are available elsewhere [Lockwood KG, Kulkarni PR, Paruthi J, et al. Evaluating a new digital app-based program for heart health: feasibility and acceptability pilot study. JMIR Form Res. May 24, 2024;8:e50446. [CrossRef] [Medline]36].

The Heart Health program targets individuals in primary prevention (ie, no history of CVD) and those in stable secondary prevention after a cardiac event. This program delivers fully remote, unlimited, real-time cardiovascular health coaching focused on digital nutrition therapy, medication adherence counseling, and personalized guidance on weight loss, physical activity, tobacco cessation, stress, and sleep. Heart Health is available to covered adult members of Lark’s health care partners via a smartphone app. Full details on the content and design of the Heart Health program are provided in previous work [Lockwood KG, Kulkarni PR, Paruthi J, et al. Evaluating a new digital app-based program for heart health: feasibility and acceptability pilot study. JMIR Form Res. May 24, 2024;8:e50446. [CrossRef] [Medline]36]. Full detail on Lark’s lifestyle change programs for diabetes prevention and hypertension care are provided elsewhere [Branch OH, Rikhy M, Auster-Gussman LA, Lockwood KG, Graham SA. Relationships between blood pressure reduction, weight loss, and engagement in a digital app-based hypertension care program: observational study. JMIR Form Res. Oct 27, 2022;6(10):e38215. [CrossRef] [Medline]37,Graham SA, Pitter V, Hori JH, Stein N, Branch OH. Weight loss in a digital app-based diabetes prevention program powered by artificial intelligence. Digit Health. 2022;8:20552076221130619. [CrossRef] [Medline]38].

Study Objective

Beyond the primary acceptability and feasibility aims, a secondary goal of the Heart Health pilot study was to determine whether CSE could improve early in this study. Specifically, we hypothesized that participants in the Heart Health pilot study who participated in the program for a minimum of 40 days would show improvement in CSE. This would indicate that a digital heart health program can help to improve CSE over a relatively short period, an important first step in developing scalable and accessible digital programs for improving self-efficacy among individuals at risk for CVD.


Study Design

This paper focuses on data from a real-world, single-arm, observational pilot study of a digital health app-based program called Lark Heart Health. The Heart Health program provides health behavior screeners and coaching to individuals at elevated risk for heart disease. The pilot study examined the feasibility of deploying screener surveys to participants of the program and the acceptability of coaching focused on building knowledge and improving self-management of atherosclerotic CVD risk. A detailed overview of study methods and primary outcomes [Lockwood KG, Kulkarni PR, Paruthi J, et al. Evaluating a new digital app-based program for heart health: feasibility and acceptability pilot study. JMIR Form Res. May 24, 2024;8:e50446. [CrossRef] [Medline]36] and predictors of interest in the program [Lockwood KG, Pitter V, Kulkarni PR, Graham SA, Auster-Gussman LA, Branch OH. Predictors of program interest in a digital health pilot study for heart health. PLOS Digit Health. Jul 31, 2023;2(7):e0000303. [CrossRef]39] have been reported in previously published works.

This study was 90 days in duration, during which participants received coaching on heart health and lifestyle modification. Participants could engage with the Heart Health program via (1) completing educational lessons, (2) engaging in coaching conversations with Lark’s conversational AI-powered digital coach, (3) logging meals in the app, and (4) tracking their weight using a digital smart scale that automatically synced with the app.

Additionally, study participation involved completion of baseline screener surveys and assessment of CSE at study start and again in month 2 (after 40 days in the program). We measured CSE in month 2 for several reasons. First, self-efficacy has been shown to improve after relatively short digital health interventions for lifestyle change (eg, 6 week programs) [Devi R, Powell J, Singh S. A web-based program improves physical activity outcomes in a primary care angina population: randomized controlled trial. J Med Internet Res. Sep 12, 2014;16(9):e186. [CrossRef] [Medline]34], particularly compared to physical health outcomes that may take months or even years to improve. Second, our study involved completing several surveys and outcome measurements that were intentionally spread out over the course of the 90 days, rather than clustering all outcome measurements at the end of this study; this approach was aimed at reducing participant burden, a crucial factor for retention in digital health programs. Third, measuring CSE early in this study enabled us to maximize the sample size of individuals actively engaging with the program who completed the survey at both time points. Between study start date and the month 2 reassessment of CSE, the Heart Health program delivered 5 weekly educational lessons focused on risk factors for heart disease, understanding cholesterol, physical activity and how it impacts blood pressure, healthy eating, and how sodium impacts blood pressure.

Ethical Considerations

All participants provided informed consent to participate in this study through an electronic consent form. The pilot study received institutional review board approval (Advarra Pro00061694). Study personnel instituted appropriate safeguards to prevent any unauthorized use or disclosure of personal health information and implemented administrative, physical, and technical safeguards to protect the confidentiality, integrity, and availability of protected health information. Lark is compliant with HIPAA (Health Insurance Portability and Accountability Act) privacy and security rules and all applicable regulations. Lark is also SOC 2 (System and Organization Controls 2) and HITRUST (Health Information Trust Alliance) certified. As compensation for study participation, participants received a cellular smart scale and opportunities for nominal gift card incentives, as well as a Fitbit (Google LLC) upon study completion. None of these incentives were tied to completion of the CSE Scale.

Participants and Study Flow

The research team recruited participants through a health care partner and via online recruitment through 1nHealth using marketing emails or SMS messages and printed mailers (health care partner recruitment only). Exclusion criteria for the study included: BMI <25 and ≥50; serious uncontrolled health conditions that had been active in the last 6 months; current pregnancy or plans to become pregnant within the next 6 months; recent history of a medical professional advising against participation in a healthy lifestyle program; a medical reason preventing 10 consecutive minutes of moderate physical exercise; and not having a smartphone with internet connection. As the Heart Health program focused heavily on improving health behaviors (eg, diet and exercise), the study also excluded individuals who reported regularly engaging in strenuous physical activity and individuals who did not report unhealthy dietary behaviors.

Participants enrolled in the pilot study from March 31 to September 15, 2022, using the Lark app (version 5.2.6), downloading the Heart Health app and providing a first weight delineated study enrollment. To be included in the present analyses, participants had to be enrolled until the end of this study (ie, did not withdraw from this study), complete the first CSE Scale at baseline for descriptive analyses, and complete the second CSE Scale at month 2 for the CSE improvement analyses. Completion of the CSE Scale occurred outside of the Lark app and full completion was not required for study participation.

Data Collection and Measures

Participant Characteristics

We assessed basic demographic and health history characteristics at baseline using a modified version of the INTERHEART Modifiable Risk Score survey [McGorrian C, Yusuf S, Islam S, et al. Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score. Eur Heart J. Mar 2011;32(5):581-589. [CrossRef] [Medline]40,Yusuf S, Rangarajan S, Teo K, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. Aug 28, 2014;371(9):818-827. [CrossRef] [Medline]41]. Items on this survey included age, sex, history of high blood pressure, tobacco use history, and typical physical activity in leisure time. Participants also provided their height and weight for calculation of BMI and the racial group they identified with.

CSE

Emails from the research team prompted participants to report on CSE shortly after study start (day 1‐2 of this study) and again in month 2 (after day 40 of this study) using a modified version of the CSE Scale. The CSE Scale evaluates individuals’ beliefs in their ability to manage their cardiovascular health and the challenges that come with heart disease using 13 questions in 3 dimensions [Sullivan MD, LaCroix AZ, Russo J, Katon WJ. Self-efficacy and self-reported functional status in coronary heart disease: a six-month prospective study. Psychosom Med. 1998;60(4):473-478. [CrossRef] [Medline]14]. The Heart Health study used 2 dimensions of the CSE Scale that are most relevant to our study sample, “control illness” and “maintain functioning,” resulting in a 9-item survey. We did not include the “control symptoms” dimension, as the questions are not relevant to individuals without a CVD diagnosis (ie, most individuals in the present sample) [Fors A, Ulin K, Cliffordson C, Ekman I, Brink E. The Cardiac Self-Efficacy Scale, a useful tool with potential to evaluate person-centred care. Eur J Cardiovasc Nurs. Dec 2015;14(6):536-543. [CrossRef] [Medline]15]. Each item is scored on a 5-point Likert scale (0=not at all confident, 1=somewhat confident, 2=moderately confident, 3=very confident, and 4=completely confident) and the total score is calculated by summing scores on each item, for a maximum score of 36. As the program did not require participants to submit the CSE Scale and permitted them to skip items, calculation of the total sum score was not possible for all study participants.

Statistical Analysis

We conducted all statistical analyses with RStudio (version 2022.07.0; R Foundation). Continuous variables were normally distributed. The first set of analyses examined relationships between baseline participant characteristics and baseline CSE Scale score. Specifically, we tested the relationship of baseline CSE with demographic characteristics (age, sex, and race), health status and health history characteristics (high blood pressure, cardiac event, or CVD diagnosis—secondary prevention, and type II diabetes), and health behaviors (tobacco use and typical physical activity in leisure time). We used bivariate regressions for continuous variables (age and BMI), independent samples t tests for categorical variables with 2 levels (sex and health history variables), and 1-way ANOVAs for categorical variables with 3 levels (race and health behaviors). Baseline CSE analyses included participants who completed the baseline CSE Scale (n=341).

To address the primary study objective, the second set of analyses tested whether there was a statistically significant change in CSE from baseline to month 2, using paired t tests (P<.05). We first tested whether there was a significant change in the CSE sum score and then whether there was improvement in each of the 9 individual items on the CSE. These analyses included all participants who completed both the baseline CSE and month 2 CSE scales (n=273).


Figure 1 shows the flow of participants through this study.

Figure 1. Flowchart of participants showing enrollment and inclusion in the analytic sample. CSE: cardiac self-efficacy.

Descriptive Statistics

We assessed descriptive statistics for baseline characteristics of participants who completed the baseline CSE Scale (n=341) and participants who completed both the baseline and month 2 CSE (n=273); both samples are shown in Table 1, as we conducted baseline descriptive analyses on the larger sample and improvement analyses on the smaller subsample (Table 1). As shown by the table, the 2 sets of participants were very similar with respect to key characteristics. Across both sets participants were, on average, aged 60 years (range=41‐76 years) and classified as obese class I (BMI range=25‐49). Just over 60% (n=207) of the participants were female, had a history of high blood pressure, and were never smokers. Approximately three-quarters of each sample reported typically being either mainly sedentary or engaging in low-effort mild exercise in their leisure time.

Table 1. Baseline characteristics of participants.
Baseline CSEa complete (n=341)Baseline and month 2 CSE complete (n=273)
Age (years), mean (SD)60 (10.1)59.3 (10.1)
Sex (female), n (%)207 (60.7)167 (61.2)
Race, n (%)
Black26 (7.6)22 (8.1)
White241 (70.7)192 (70.3)
Other70 (20.5)57 (20.9)
Recruitment source (health partner), n (%)207 (60.7)154 (56.4)
Baseline BMI, mean (SD)32.8 (5.8)32.9 (5.9)
High blood pressure history, n (%)198 (58.1)162 (59.3)
History of CVDb diagnosis or event, n (%)41 (12.0)34 (12.5)
Type II diabetes history, n (%)52 (15.2)37 (13.6)
Tobacco use status, n (%)
Never203 (59.5)171 (62.6)
Former110 (32.3)82 (30.0)
Current27 (7.9)19 (6.9)
Physical activity in leisure time, n (%)
Mainly sedentary121 (35.5)94 (34.4)
Mild exercise, low effort145 (42.5)116 (42.5)
Moderate exercise72 (21.1)61 (22.3)
Baseline CSE score, mean (SD)25.1 (7.3)25.1 (7.3)

aCSE: cardiac self-efficacy.

bCVD: cardiovascular disease.

Relationships Between Baseline CSE Scores and Participant Characteristics

Next, we examined relationships between baseline participant characteristics and baseline CSE Scale scores for all participants who completed the baseline CSE Scale. Of the demographic characteristics, age was significantly associated with CSE, such that CSE increased with age (n=341, β=.12, SE=0.04, P=.03). There was no statistically significant difference in baseline CSE by sex (t338=0.19, P=.43) or racial group (F340=2.72, P=.07).

Among the health history characteristics, participants with a history of type II diabetes tended to have higher baseline CSE (mean 27.48, SD 6.47, n=52) compared to participants without diabetes history (mean 24.71, SD 7.42, n=289; t77=2.78, P=.003). There was no difference in baseline CSE between participants with a history of high blood pressure and those without (t322=0.91, P=.36) or participants in primary prevention versus secondary prevention (t50=0.57, P=.57). There was also a significant association between BMI and CSE, with lower BMI individuals reporting higher CSE (n=341, β=−.11, SE=0.07, P=.047).

For the health behavior variables, there was no difference in CSE based on tobacco use status (F339=1.61, P=.20) or typical physical activity in leisure time (F337=1.51, P=.22)

Change in CSE From Baseline to Month 2

In testing for changes in the CSE from baseline to month 2, we found a significant increase in the overall sum score on the CSE Scale from baseline to month 2 (Table 2). There were also significant increases in each individual item on the CSE (all P<.001). The individual CSE items with the greatest increases were “confidence in knowing when to call or visit the doctor,” “confidence in knowing how much physical activity is good for you,” and “confidence that you can get regular aerobic exercise.

Table 2. Changes in CSEa score from baseline to month 2 (n=273)b. The baseline CSE survey was surfaced to participants on day 2, and the month 2 CSE survey was deployed on day 40.
Baseline, mean (SD)Month 2, mean (SD)Baseline to month 2, raw changeBaseline to month 2, change in %t test (df)P value
How confident are you that you know…
When to call or visit your doctor about your heart disease?2.7 (1.1)3.1 (0.9)+0.5+177.9 (272)<.001
How to make your doctor understand your concerns about your heart?2.8 (1.1)3.1 (0.9)+0.3+10.75.1 (272)<.001
How to take your cardiac medications?3.1 (1.1)3.4 (0.9)+0.4+11.45.7 (272)<.001
How much physical activity is good for you?2.7 (1.1)3.2 (0.8)+0.5+16.37.7 (272)<.001
How confident are you that you can...
Maintain your social activities?2.8 (1)3.2 (0.8)+0.4+136.4 (272)<.001
Maintain your usual activities at home with your family?3 (1)3.3 (0.8)+0.2+7.74.2 (272)<.001
Maintain your usual activities at work?2.9 (1.1)3.2 (0.9)+0.3+10.74.8 (272)<.001
Maintain your sexual relationship with your spouse?2.6 (1.3)2.9 (1.1)+0.3+12.34.3 (272)<.001
Get regular aerobic exercise?2.5 (1.2)2.9 (1.1)+0.5+196.4 (272)<.001
Overall sum score on the CSE25.07 (7.3)28.3 (6.3)+3.2+12.99.2 (272)<.001

aCSE: cardiac self-efficacy.

bn=273 participants submitted the cardiac self-efficacy with all items completed.


Summary and Interpretation of Results

These analyses examined improvement in CSE as a secondary goal in a digital lifestyle modification program for heart health focused on AI-supported health coaching, educational lessons, behavioral tracking, and weight management. We found that the overall CSE Scale score improved significantly from baseline to month 2 of the program. Moreover, mean scores on each individual item of the CSE increased significantly over this short period, with the largest increases in patients’ confidence in knowing when to contact their doctor about their heart health (+17%) and items related to confidence in knowing how much physical activity to do (+16.3%) and getting regular exercise (+19%). The results of these secondary analyses of the Heart Health program pilot study support the assertion that digital health programs can play an important role in increasing self-efficacy to better manage their health over a relatively short period.

This study is the first digital health study we are aware of to show improvements in CSE scores through participation in a digital lifestyle modification program for heart health. There is evidence that in-person lifestyle change programs for CVD can improve CSE [Bagheri H, Shakeri S, Nazari AM, et al. Effectiveness of nurse-led counselling and education on self-efficacy of patients with acute coronary syndrome: a randomized controlled trial. Nurs Open. Jan 2022;9(1):775-784. [CrossRef] [Medline]25,McKenzie KM, Park LK, Lenze EJ, et al. A prospective cohort study of the impact of outpatient intensive cardiac rehabilitation on depression and cardiac self-efficacy. Am Heart J Plus. Jan 2022;13:100100. [CrossRef] [Medline]26], and literature showing that digital interventions can increase general self-efficacy [Devi R, Powell J, Singh S. A web-based program improves physical activity outcomes in a primary care angina population: randomized controlled trial. J Med Internet Res. Sep 12, 2014;16(9):e186. [CrossRef] [Medline]34,Newby K, Teah G, Cooke R, et al. Do automated digital health behaviour change interventions have a positive effect on self-efficacy? A systematic review and meta-analysis. Health Psychol Rev. Mar 2021;15(1):140-158. [CrossRef] [Medline]35]. These results are consistent with results from 2 prior studies with cardiac patients showing that in-person intervention programs for CVD management can improve CSE scores; however, these in-person programs involved intensive, human-led interventions that required significant staffing and economic resources [Bagheri H, Shakeri S, Nazari AM, et al. Effectiveness of nurse-led counselling and education on self-efficacy of patients with acute coronary syndrome: a randomized controlled trial. Nurs Open. Jan 2022;9(1):775-784. [CrossRef] [Medline]25,McKenzie KM, Park LK, Lenze EJ, et al. A prospective cohort study of the impact of outpatient intensive cardiac rehabilitation on depression and cardiac self-efficacy. Am Heart J Plus. Jan 2022;13:100100. [CrossRef] [Medline]26].

One recent study using a 60-day text message intervention implemented in patients recently discharged after acute coronary syndrome had no significant effect on the CSE [Ross ES, Sakakibara BM, Mackay MH, et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth uHealth. May 14, 2021;9(5):e24530. [CrossRef] [Medline]42]. The researchers implemented an automated 1-way text message campaign through which patients received messages about self-management, healthy living, and follow-up care. There are many key differences in the study design by Ross et al [Ross ES, Sakakibara BM, Mackay MH, et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth uHealth. May 14, 2021;9(5):e24530. [CrossRef] [Medline]42] compared to our study, but it is possible that we found improvements in CSE because the Heart Health program involves 2-way interaction with AI-supported coaching and active behavior tracking, rather than a 1-way messaging system.

It is also notable that 2 of the CSE items with the biggest improvement from baseline to month 2 were centered on confidence related to physical activity: “confidence in knowing how much physical activity is good for you” (+16%), and “confidence that you can get regular aerobic exercise (+19%). Education on physical activity is a key component of the Heart Health program, with an educational lesson on Physical Activity for Low Blood Pressure delivered during the third weekly lesson in the program. The Heart Health digital coach also provides ongoing interactive coaching on physical activity, encouraging participants to log their physical activity in the app. As such, the present results suggest that the education and coaching in the first 2 months of the Heart Health program support improvements in confidence related to physical activity. Similarly, prior work has shown that digital health interventions focused on physical activity can improve exercise-related self-efficacy over 24 weeks [Maddison R, Pfaeffli L, Whittaker R, et al. A mobile phone intervention increases physical activity in people with cardiovascular disease: results from the HEART randomized controlled trial. Eur J Prev Cardiolog. Jun 2015;22(6):701-709. [CrossRef]43]. Future research in this area could examine whether improvements in CSE Scale score during the first 2 months of the program predict longitudinal increases in physical activity.

Beyond the primary results of these analyses, we also found several relationships between baseline CSE score and participant characteristics. Specifically, we found that older age, lower BMI, and having a history of type II diabetes were all associated with having higher CSE scores at baseline. Importantly, a significant body of literature has shown that higher self-efficacy among older persons is associated with a range of positive health benefits, including increased self-care, better health behaviors, increased energy, and decreased pain and discomfort [Kostka T, Jachimowicz V. Relationship of quality of life to dispositional optimism, health locus of control and self-efficacy in older subjects living in different environments. Qual Life Res. Apr 2010;19(3):351-361. [CrossRef] [Medline]44,Anderson ES, Winett RA, Wojcik JR, Williams DM. Social cognitive mediators of change in a group randomized nutrition and physical activity intervention: social support, self-efficacy, outcome expectations and self-regulation in the guide-to-health trial. J Health Psychol. Jan 2010;15(1):21-32. [CrossRef] [Medline]45]. This is particularly relevant to our study, as participants in this sample tended to be older adults, with a mean age of 60 years and up to 76 years. Notably, the broader literature indicates that self-efficacy and closely related constructs, such as self-esteem, tend to increase with age due to increasing knowledge and maturity, greater control over life circumstances, higher likelihood of occupying positions of power and status, and improved coping resources and processes [Orth U, Trzesniewski KH, Robins RW. Self-esteem development from young adulthood to old age: a cohort-sequential longitudinal study. J Pers Soc Psychol. Apr 2010;98(4):645-658. [CrossRef] [Medline]46]. Indeed, a large meta-analysis of 164,868 participants showed that self-esteem tends to increase steadily with age, reaching peak levels between ages 60‐70 before declining slightly after age 70 and steeply after age 90 [Orth U, Erol RY, Luciano EC. Development of self-esteem from age 4 to 94 years: a meta-analysis of longitudinal studies. Psychol Bull. Oct 2018;144(10):1045-1080. [CrossRef] [Medline]47].

Our finding that lower BMI was associated with high CSE scores aligns with prior work showing that cardiac patients with lower BMI also tended to have higher CSE [Kang Y, Yang IS. Cardiac self-efficacy and its predictors in patients with coronary artery diseases. J Clin Nurs. Sep 2013;22(17-18):2465-2473. [CrossRef] [Medline]48] and with population-based research showing lower health-related self-efficacy among individuals with higher BMI [Ovaskainen ML, Tapanainen H, Laatikainen T, Männistö S, Heinonen H, Vartiainen E. Perceived health-related self-efficacy associated with BMI in adults in a population-based survey. Scand J Public Health. Mar 2015;43(2):197-203. [CrossRef]49]. This relationship may be due to individuals with higher BMI having a history of difficulty managing their weight and lower self-esteem [Kiviruusu O, Konttinen H, Huurre T, Aro H, Marttunen M, Haukkala A. Self-esteem and body mass index from adolescence to mid-adulthood. a 26-year follow-up. IntJ Behav Med. Jun 2016;23(3):355-363. [CrossRef]50], factors that are closely related to self-efficacy.

The link between the history of type II diabetes and baseline CSE is also consistent with prior literature showing that patients with a history of chronic disease diagnosis tend to have higher CSE [Kang Y, Yang IS. Cardiac self-efficacy and its predictors in patients with coronary artery diseases. J Clin Nurs. Sep 2013;22(17-18):2465-2473. [CrossRef] [Medline]48,Shrestha R, Rawal L, Bajracharya R, Ghimire A. Predictors of cardiac self-efficacy among patients diagnosed with coronary artery disease in tertiary hospitals in Nepal. J Public Health Res. Oct 14, 2020;9(4):1787. [CrossRef] [Medline]51]. This relationship is likely due to these individuals already having some experience with managing a health condition and potentially receiving prior education on managing cardiometabolic conditions. However, it is surprising that a history of high blood pressure and history of cardiac events or CVD diagnoses were not associated with differences in baseline CSE in this study’s sample.

Limitations and Future Directions

There are several limitations to our results. First, data for these secondary analyses came from an observational pilot study focused on the acceptability and feasibility of a new digital heart health program. As such, these results should be considered preliminary, rather than conclusive. We were also unable to compare these results to a control group, and causal conclusions are limited. Additionally, participants could opt out of any survey, including the CSE survey, if they did not wish to complete it. As a result, we could only include individuals in these analyses if they submitted a complete CSE Scale. Completion of the CSE Scale also occurred outside of the Lark app to be used for pilot study purposes only. Thus, the sample may be biased toward participants who were more engaged in the program or more likely to check their emails. The CSE Scale is also limited as it includes questions about confidence in work settings and in marital life, which may not apply to all participants. Finally, this digital intervention was limited to those with a smartphone with internet access who had sufficient digital literacy to use the Lark app. As a result, this may exclude individuals of lower socioeconomic status. For instance, the 2024 Pew Research Center data showed that, although 90% of US adults have a smartphone, individuals in the lowest income bracket (US <$30,000/year) have lower rates of smartphone ownership (79%) compared to those in higher income brackets (US >$100,000/year; 98%) [Gelles-Watnick R. Rates of smartphone ownership, broadband subscription vary across groups, including by household income and education. Pew Research Center. 2024. URL: https:/​/www.​pewresearch.org/​internet/​2024/​01/​31/​americans-use-of-mobile-technology-and-home-broadband/​ [Accessed 2025-04-04] 52].

The pilot study results presented here provide a foundation for several lines of future work. For instance, future work including a control group can provide causal evidence for the impact of the Heart Health program on CSE. Additionally, a key future direction for this study will be assessing whether increased CSE predicts longitudinal clinical outcomes. Given that the duration of the pilot study was only a short period of 90 days, we did not expect to see a meaningful relationship between improved CSE Scale scores and clinical outcomes. This is particularly true given that we measured CSE improvements nearly halfway through the program. Future research could examine longitudinal changes in CVD risk factors, such as blood pressure or cholesterol levels. Based on the literature, we would expect that improvements in CSE would predict improved cardiovascular outcomes.

Conclusions

In summary, the present analyses indicate that participants in a digital lifestyle modification program for heart health showed significant improvements in CSE within 2 months. This work adds to the growing literature examining ways to improve health-related self-efficacy for the prevention and management of chronic disease and long-term health benefits.

Acknowledgments

The Heart Health pilot study was supported by funds from Roche Information Solutions and Lark Health. KGL, OHB, and SAG received salaries from Lark Health. PRK received a salary from Roche Information Solutions.

Data Availability

The dataset analyzed during this study is not publicly available as these analyses include sensitive, potentially identifiable information that was obtained through a collaboration between Lark Health and its health care partners, but data may be available from the corresponding author upon reasonable request.

Authors' Contributions

All authors contributed to the conception of the work and made critical revisions to the content of this paper. KGL contributed to data collection and management, led data analysis, and drafted and revised this paper. PRK and SAG provided critical reviews and interpretation of all statistical analyses. OHB was the principal investigator of the pilot study, supervised data collection and management, and supported analyses and interpretation of the data.

Conflicts of Interest

KGL, OHB, and SAG were employees of Lark Health at the time of manuscript development. PRK is an employee of Roche Information Solutions.

  1. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. Feb 22, 2022;145(8):e153-e639. [CrossRef] [Medline]
  2. McClellan M, Brown N, Califf RM, Warner JJ. Call to action: urgent challenges in cardiovascular disease: a presidential advisory from the American Heart Association. Circulation. Feb 26, 2019;139(9):e44-e54. [CrossRef] [Medline]
  3. Rippe JM. Lifestyle strategies for risk factor reduction, prevention, and treatment of cardiovascular disease. Am J Lifestyle Med. 2019;13(2):204-212. [CrossRef] [Medline]
  4. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. Sep 10, 2019;140(11):e596-e646. [CrossRef] [Medline]
  5. Kris-Etherton PM, Petersen KS, Velarde G, et al. Barriers, opportunities, and challenges in addressing disparities in diet-related cardiovascular disease in the United States. J Am Heart Assoc. Apr 7, 2020;9(7):e014433. [CrossRef] [Medline]
  6. US Preventive Services Task Force, Krist AH, Davidson KW, et al. Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: US Preventive Services Task Force recommendation statement. JAMA. Nov 24, 2020;324(20):2069-2075. [CrossRef] [Medline]
  7. Patnode CD, Redmond N, Iacocca MO, Henninger M. Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults without known cardiovascular disease risk factors: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. Jul 26, 2022;328(4):375-388. [CrossRef] [Medline]
  8. US Preventive Services Task Force, Mangione CM, Barry MJ, et al. Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults without cardiovascular disease risk factors: US Preventive Services Task Force recommendation statement. JAMA. Jul 26, 2022;328(4):367-374. [CrossRef] [Medline]
  9. Foroumandi E, Kheirouri S, Alizadeh M. The potency of education programs for management of blood pressure through increasing self-efficacy of hypertensive patients: a systematic review and meta-analysis. Patient Educ Couns. Mar 2020;103(3):451-461. [CrossRef] [Medline]
  10. Katch H, Mead H. The role of self-efficacy in cardiovascular disease self-management: a review of effective programs. PI. 2010;2010(2):33-44. [CrossRef]
  11. Brady TJ, Murphy L, O’Colmain BJ, et al. A meta-analysis of health status, health behaviors, and health care utilization outcomes of the Chronic Disease Self-Management Program. Prev Chronic Dis. 2013;10:120112. [CrossRef] [Medline]
  12. Lorig K, Stewart A, Ritter P, González V, et al. Outcome Measures for Health Education and Other Health Care Interventions. Sage Publications, Inc; 1996. ISBN: 978-0-7619-0066-5
  13. Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001;4(6):256-262. [Medline]
  14. Sullivan MD, LaCroix AZ, Russo J, Katon WJ. Self-efficacy and self-reported functional status in coronary heart disease: a six-month prospective study. Psychosom Med. 1998;60(4):473-478. [CrossRef] [Medline]
  15. Fors A, Ulin K, Cliffordson C, Ekman I, Brink E. The Cardiac Self-Efficacy Scale, a useful tool with potential to evaluate person-centred care. Eur J Cardiovasc Nurs. Dec 2015;14(6):536-543. [CrossRef] [Medline]
  16. Ea EE, Colbert A, Turk M, Dickson VV. Self-care among Filipinos in the United States who have hypertension. Appl Nurs Res. Feb 2018;39:71-76. [CrossRef] [Medline]
  17. Tan F, Oka P, Dambha-Miller H, Tan NC. The association between self-efficacy and self-care in essential hypertension: a systematic review. BMC Fam Pract. Feb 22, 2021;22(1):44. [CrossRef] [Medline]
  18. Garland M, Wilbur J, Fogg L, Halloway S, Braun L, Miller A. Self-efficacy, outcome expectations, group social support, and adherence to physical activity in African American women. Nurs Res. 2021;70(4):239-247. [CrossRef] [Medline]
  19. Kang A, Dulin A, Risica PM. Relationship between adherence to diet and physical activity guidelines and self-efficacy among black women with high blood pressure. J Health Psychol. Mar 2022;27(3):663-673. [CrossRef] [Medline]
  20. Warren-Findlow J, Seymour RB. Prevalence rates of hypertension self-care activities among African Americans. J Natl Med Assoc. Jun 2011;103(6):503-512. [CrossRef] [Medline]
  21. Jackson L, Leclerc J, Erskine Y, Linden W. Getting the most out of cardiac rehabilitation: a review of referral and adherence predictors. Heart. Jan 2005;91(1):10-14. [CrossRef] [Medline]
  22. Banik A, Schwarzer R, Knoll N, Czekierda K, Luszczynska A. Self-efficacy and quality of life among people with cardiovascular diseases: a meta-analysis. Rehabil Psychol. May 2018;63(2):295-312. [CrossRef] [Medline]
  23. Lorig KR, Ritter PL, González VM. Hispanic chronic disease self-management: a randomized community-based outcome trial. Nurs Res. 2003;52(6):361-369. [CrossRef] [Medline]
  24. DeWalt DA, Pignone M, Malone R, et al. Development and pilot testing of a disease management program for low literacy patients with heart failure. Patient Educ Couns. Oct 2004;55(1):78-86. [CrossRef] [Medline]
  25. Bagheri H, Shakeri S, Nazari AM, et al. Effectiveness of nurse-led counselling and education on self-efficacy of patients with acute coronary syndrome: a randomized controlled trial. Nurs Open. Jan 2022;9(1):775-784. [CrossRef] [Medline]
  26. McKenzie KM, Park LK, Lenze EJ, et al. A prospective cohort study of the impact of outpatient intensive cardiac rehabilitation on depression and cardiac self-efficacy. Am Heart J Plus. Jan 2022;13:100100. [CrossRef] [Medline]
  27. Kang Y, Yang IS, Kim N. Correlates of health behaviors in patients with coronary artery disease. Asian Nurs Res (Korean Soc Nurs Sci). Mar 2010;4(1):45-55. [CrossRef] [Medline]
  28. Sarkar U, Ali S, Whooley MA. Self-efficacy as a marker of cardiac function and predictor of heart failure hospitalization and mortality in patients with stable coronary heart disease: findings from the Heart and Soul Study. Health Psychol. Mar 2009;28(2):166-173. [CrossRef] [Medline]
  29. Mahajan S, Lu Y, Spatz ES, Nasir K, Krumholz HM. Trends and predictors of use of digital health technology in the United States. Am J Med. Jan 2021;134(1):129-134. [CrossRef] [Medline]
  30. Wongvibulsin S, Habeos EE, Huynh PP, et al. Digital health interventions for cardiac rehabilitation: systematic literature review. J Med Internet Res. Feb 8, 2021;23(2):e18773. [CrossRef] [Medline]
  31. Zwack CC, Haghani M, Hollings M, et al. The evolution of digital health technologies in cardiovascular disease research. npj Digit Med. Jan 3, 2023;6(1):1-11. [CrossRef]
  32. Frederix I, Caiani EG, Dendale P, et al. ESC e-Cardiology Working Group position paper: overcoming challenges in digital health implementation in cardiovascular medicine. Eur J Prev Cardiol. Jul 2019;26(11):1166-1177. [CrossRef] [Medline]
  33. Gray R, Indraratna P, Lovell N, Ooi SY. Digital health technology in the prevention of heart failure and coronary artery disease. Cardiovasc Digit Health J. Dec 2022;3(6 Suppl):S9-S16. [CrossRef] [Medline]
  34. Devi R, Powell J, Singh S. A web-based program improves physical activity outcomes in a primary care angina population: randomized controlled trial. J Med Internet Res. Sep 12, 2014;16(9):e186. [CrossRef] [Medline]
  35. Newby K, Teah G, Cooke R, et al. Do automated digital health behaviour change interventions have a positive effect on self-efficacy? A systematic review and meta-analysis. Health Psychol Rev. Mar 2021;15(1):140-158. [CrossRef] [Medline]
  36. Lockwood KG, Kulkarni PR, Paruthi J, et al. Evaluating a new digital app-based program for heart health: feasibility and acceptability pilot study. JMIR Form Res. May 24, 2024;8:e50446. [CrossRef] [Medline]
  37. Branch OH, Rikhy M, Auster-Gussman LA, Lockwood KG, Graham SA. Relationships between blood pressure reduction, weight loss, and engagement in a digital app-based hypertension care program: observational study. JMIR Form Res. Oct 27, 2022;6(10):e38215. [CrossRef] [Medline]
  38. Graham SA, Pitter V, Hori JH, Stein N, Branch OH. Weight loss in a digital app-based diabetes prevention program powered by artificial intelligence. Digit Health. 2022;8:20552076221130619. [CrossRef] [Medline]
  39. Lockwood KG, Pitter V, Kulkarni PR, Graham SA, Auster-Gussman LA, Branch OH. Predictors of program interest in a digital health pilot study for heart health. PLOS Digit Health. Jul 31, 2023;2(7):e0000303. [CrossRef]
  40. McGorrian C, Yusuf S, Islam S, et al. Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score. Eur Heart J. Mar 2011;32(5):581-589. [CrossRef] [Medline]
  41. Yusuf S, Rangarajan S, Teo K, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. Aug 28, 2014;371(9):818-827. [CrossRef] [Medline]
  42. Ross ES, Sakakibara BM, Mackay MH, et al. The use of SMS text messaging to improve the hospital-to-community transition in patients with acute coronary syndrome (Txt2Prevent): results from a pilot randomized controlled trial. JMIR mHealth uHealth. May 14, 2021;9(5):e24530. [CrossRef] [Medline]
  43. Maddison R, Pfaeffli L, Whittaker R, et al. A mobile phone intervention increases physical activity in people with cardiovascular disease: results from the HEART randomized controlled trial. Eur J Prev Cardiolog. Jun 2015;22(6):701-709. [CrossRef]
  44. Kostka T, Jachimowicz V. Relationship of quality of life to dispositional optimism, health locus of control and self-efficacy in older subjects living in different environments. Qual Life Res. Apr 2010;19(3):351-361. [CrossRef] [Medline]
  45. Anderson ES, Winett RA, Wojcik JR, Williams DM. Social cognitive mediators of change in a group randomized nutrition and physical activity intervention: social support, self-efficacy, outcome expectations and self-regulation in the guide-to-health trial. J Health Psychol. Jan 2010;15(1):21-32. [CrossRef] [Medline]
  46. Orth U, Trzesniewski KH, Robins RW. Self-esteem development from young adulthood to old age: a cohort-sequential longitudinal study. J Pers Soc Psychol. Apr 2010;98(4):645-658. [CrossRef] [Medline]
  47. Orth U, Erol RY, Luciano EC. Development of self-esteem from age 4 to 94 years: a meta-analysis of longitudinal studies. Psychol Bull. Oct 2018;144(10):1045-1080. [CrossRef] [Medline]
  48. Kang Y, Yang IS. Cardiac self-efficacy and its predictors in patients with coronary artery diseases. J Clin Nurs. Sep 2013;22(17-18):2465-2473. [CrossRef] [Medline]
  49. Ovaskainen ML, Tapanainen H, Laatikainen T, Männistö S, Heinonen H, Vartiainen E. Perceived health-related self-efficacy associated with BMI in adults in a population-based survey. Scand J Public Health. Mar 2015;43(2):197-203. [CrossRef]
  50. Kiviruusu O, Konttinen H, Huurre T, Aro H, Marttunen M, Haukkala A. Self-esteem and body mass index from adolescence to mid-adulthood. a 26-year follow-up. IntJ Behav Med. Jun 2016;23(3):355-363. [CrossRef]
  51. Shrestha R, Rawal L, Bajracharya R, Ghimire A. Predictors of cardiac self-efficacy among patients diagnosed with coronary artery disease in tertiary hospitals in Nepal. J Public Health Res. Oct 14, 2020;9(4):1787. [CrossRef] [Medline]
  52. Gelles-Watnick R. Rates of smartphone ownership, broadband subscription vary across groups, including by household income and education. Pew Research Center. 2024. URL: https:/​/www.​pewresearch.org/​internet/​2024/​01/​31/​americans-use-of-mobile-technology-and-home-broadband/​ [Accessed 2025-04-04]


AI: artificial intelligence
CSE: cardiac self-efficacy
CVD: cardiovascular disease
HIPAA: Health Insurance Portability and Accountability Act
HITRUST: Health Information Trust Alliance
SOC 2: System and Organization Controls 2


Edited by Amaryllis Mavragani; submitted 17.05.24; peer-reviewed by Amie Woodward, Katarzyna Wac; final revised version received 28.02.25; accepted 02.03.25; published 24.04.25.

Copyright

© Kimberly G Lockwood, Priya R Kulkarni, OraLee H Branch, Sarah A Graham. Originally published in JMIR Formative Research (https://formative.jmir.org), 24.4.2025.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included.